Mass media release of medical research results

An analysis of antihypertensive drug prescribing in the aftermath of the calcium channel blocker scare of March 1995

Margaret E. Brunt, Michael Murray, Siu Hui, Joseph Kesterson, Anthony J. Perkins, William M. Tierney

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

BACKGROUND: Disclosure of medical research results to the public creates tension between lay medical reporters and the medical profession. OBJECTIVE: To explore the early effect of media attention on the risks associated with short-acting calcium channel blockers (CCBs) for treating hypertension after publication at a national meeting and following publication. DESIGN: Time-series analysis of prescription claims data. SETTING AND DATA SOURCE: National third-party pharmaceutical benefits manager. PATIENTS: Employed or retired persons and their families, 18 years of age or older, receiving prescription benefits from 1 of 4 national companies that contracted with the pharmaceutical benefits manager exclusively for prescription drug coverage. MEASUREMENTS: Prescription claims for antihypertensive drugs by fill date converted to a percentage of all cardiovascular drug claims. Data were grouped into weekly intervals before and immediately after the national release of negative information about CCBs on March 10, 1995 and following publication of the results on August 23, 1995. RESULTS: The most prevalent antihypertensive drugs were diuretics (21% of cardiovascular prescription claims) and calcium channel blockers (19%). A 10% decline in prescriptions filled for CCBs occurred 4 weeks following the intense media attention. Only prescriptions for long-acting calcium channel blockers declined. Alpha-1-blocker prescriptions increased by approximately the same amount that prescriptions for CCBs declined, suggesting substitution of one drug for the other. Changes in diuretic or β-blocker prescriptions filled were not statistically significant. No immediate change in other cardiovascular drug classes occurred following journal publication. CONCLUSIONS: Intense media publicity regarding a controversial study measurably and unpredictably changed prescription claims.

Original languageEnglish
Pages (from-to)84-94
Number of pages11
JournalJournal of General Internal Medicine
Volume18
Issue number2
DOIs
StatePublished - Feb 1 2003

Fingerprint

Drug Prescriptions
Mass Media
Calcium Channel Blockers
Antihypertensive Agents
Prescriptions
Biomedical Research
Publications
Cardiovascular Agents
Diuretics
Insurance Claim Review
Drug Substitution
Prescription Drugs
Disclosure
Pharmaceutical Preparations
Hypertension

Keywords

  • Calcium channel blockers
  • Communication
  • Hypertension
  • Media

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Mass media release of medical research results : An analysis of antihypertensive drug prescribing in the aftermath of the calcium channel blocker scare of March 1995. / Brunt, Margaret E.; Murray, Michael; Hui, Siu; Kesterson, Joseph; Perkins, Anthony J.; Tierney, William M.

In: Journal of General Internal Medicine, Vol. 18, No. 2, 01.02.2003, p. 84-94.

Research output: Contribution to journalArticle

@article{2020833b98854c47bec368426410b31e,
title = "Mass media release of medical research results: An analysis of antihypertensive drug prescribing in the aftermath of the calcium channel blocker scare of March 1995",
abstract = "BACKGROUND: Disclosure of medical research results to the public creates tension between lay medical reporters and the medical profession. OBJECTIVE: To explore the early effect of media attention on the risks associated with short-acting calcium channel blockers (CCBs) for treating hypertension after publication at a national meeting and following publication. DESIGN: Time-series analysis of prescription claims data. SETTING AND DATA SOURCE: National third-party pharmaceutical benefits manager. PATIENTS: Employed or retired persons and their families, 18 years of age or older, receiving prescription benefits from 1 of 4 national companies that contracted with the pharmaceutical benefits manager exclusively for prescription drug coverage. MEASUREMENTS: Prescription claims for antihypertensive drugs by fill date converted to a percentage of all cardiovascular drug claims. Data were grouped into weekly intervals before and immediately after the national release of negative information about CCBs on March 10, 1995 and following publication of the results on August 23, 1995. RESULTS: The most prevalent antihypertensive drugs were diuretics (21{\%} of cardiovascular prescription claims) and calcium channel blockers (19{\%}). A 10{\%} decline in prescriptions filled for CCBs occurred 4 weeks following the intense media attention. Only prescriptions for long-acting calcium channel blockers declined. Alpha-1-blocker prescriptions increased by approximately the same amount that prescriptions for CCBs declined, suggesting substitution of one drug for the other. Changes in diuretic or β-blocker prescriptions filled were not statistically significant. No immediate change in other cardiovascular drug classes occurred following journal publication. CONCLUSIONS: Intense media publicity regarding a controversial study measurably and unpredictably changed prescription claims.",
keywords = "Calcium channel blockers, Communication, Hypertension, Media",
author = "Brunt, {Margaret E.} and Michael Murray and Siu Hui and Joseph Kesterson and Perkins, {Anthony J.} and Tierney, {William M.}",
year = "2003",
month = "2",
day = "1",
doi = "10.1046/j.1525-1497.2003.20502.x",
language = "English",
volume = "18",
pages = "84--94",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Mass media release of medical research results

T2 - An analysis of antihypertensive drug prescribing in the aftermath of the calcium channel blocker scare of March 1995

AU - Brunt, Margaret E.

AU - Murray, Michael

AU - Hui, Siu

AU - Kesterson, Joseph

AU - Perkins, Anthony J.

AU - Tierney, William M.

PY - 2003/2/1

Y1 - 2003/2/1

N2 - BACKGROUND: Disclosure of medical research results to the public creates tension between lay medical reporters and the medical profession. OBJECTIVE: To explore the early effect of media attention on the risks associated with short-acting calcium channel blockers (CCBs) for treating hypertension after publication at a national meeting and following publication. DESIGN: Time-series analysis of prescription claims data. SETTING AND DATA SOURCE: National third-party pharmaceutical benefits manager. PATIENTS: Employed or retired persons and their families, 18 years of age or older, receiving prescription benefits from 1 of 4 national companies that contracted with the pharmaceutical benefits manager exclusively for prescription drug coverage. MEASUREMENTS: Prescription claims for antihypertensive drugs by fill date converted to a percentage of all cardiovascular drug claims. Data were grouped into weekly intervals before and immediately after the national release of negative information about CCBs on March 10, 1995 and following publication of the results on August 23, 1995. RESULTS: The most prevalent antihypertensive drugs were diuretics (21% of cardiovascular prescription claims) and calcium channel blockers (19%). A 10% decline in prescriptions filled for CCBs occurred 4 weeks following the intense media attention. Only prescriptions for long-acting calcium channel blockers declined. Alpha-1-blocker prescriptions increased by approximately the same amount that prescriptions for CCBs declined, suggesting substitution of one drug for the other. Changes in diuretic or β-blocker prescriptions filled were not statistically significant. No immediate change in other cardiovascular drug classes occurred following journal publication. CONCLUSIONS: Intense media publicity regarding a controversial study measurably and unpredictably changed prescription claims.

AB - BACKGROUND: Disclosure of medical research results to the public creates tension between lay medical reporters and the medical profession. OBJECTIVE: To explore the early effect of media attention on the risks associated with short-acting calcium channel blockers (CCBs) for treating hypertension after publication at a national meeting and following publication. DESIGN: Time-series analysis of prescription claims data. SETTING AND DATA SOURCE: National third-party pharmaceutical benefits manager. PATIENTS: Employed or retired persons and their families, 18 years of age or older, receiving prescription benefits from 1 of 4 national companies that contracted with the pharmaceutical benefits manager exclusively for prescription drug coverage. MEASUREMENTS: Prescription claims for antihypertensive drugs by fill date converted to a percentage of all cardiovascular drug claims. Data were grouped into weekly intervals before and immediately after the national release of negative information about CCBs on March 10, 1995 and following publication of the results on August 23, 1995. RESULTS: The most prevalent antihypertensive drugs were diuretics (21% of cardiovascular prescription claims) and calcium channel blockers (19%). A 10% decline in prescriptions filled for CCBs occurred 4 weeks following the intense media attention. Only prescriptions for long-acting calcium channel blockers declined. Alpha-1-blocker prescriptions increased by approximately the same amount that prescriptions for CCBs declined, suggesting substitution of one drug for the other. Changes in diuretic or β-blocker prescriptions filled were not statistically significant. No immediate change in other cardiovascular drug classes occurred following journal publication. CONCLUSIONS: Intense media publicity regarding a controversial study measurably and unpredictably changed prescription claims.

KW - Calcium channel blockers

KW - Communication

KW - Hypertension

KW - Media

UR - http://www.scopus.com/inward/record.url?scp=0037325903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037325903&partnerID=8YFLogxK

U2 - 10.1046/j.1525-1497.2003.20502.x

DO - 10.1046/j.1525-1497.2003.20502.x

M3 - Article

VL - 18

SP - 84

EP - 94

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - 2

ER -